(NYSE: TFX) Teleflex's forecast annual revenue growth rate of -3.17% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.02%.
Teleflex's revenue in 2026 is $2,811,156,000.On average, 14 Wall Street analysts forecast TFX's revenue for 2026 to be $102,308,457,621, with the lowest TFX revenue forecast at $98,899,651,374, and the highest TFX revenue forecast at $106,779,748,932. On average, 13 Wall Street analysts forecast TFX's revenue for 2027 to be $107,576,612,730, with the lowest TFX revenue forecast at $103,548,023,529, and the highest TFX revenue forecast at $112,977,578,472.
In 2028, TFX is forecast to generate $113,021,848,683 in revenue, with the lowest revenue forecast at $108,727,638,216 and the highest revenue forecast at $118,555,625,058.